Clinical Trial Finds Coffee Consumption Reduces Recurrent Atrial Fibrillation Risk
By
stared
Crusty in the right places. Worth the chew.
Summary
A multicenter randomized clinical trial (DECAF) involving 200 patients with persistent atrial fibrillation (AF) undergoing cardioversion found that those allocated to consume caffeinated coffee had a significantly lower risk of recurrent AF (47%) compared to those who abstained from coffee and caffeine (64%). The study suggests that coffee consumption may be reasonably considered for patients with AF, challenging previous assumptions about caffeine's negative effects on heart rhythm disorders.
Key quotes
· 3 pulledIn this multicenter randomized clinical trial including 200 patients with persistent AF undergoing cardioversion, the risk of recurrent AF was significantly lower in the group allocated to coffee consumption (47%) compared with the abstinence group (64%).
Consumption of coffee and other caffeinated products may be reasonably considered for patients with atrial fibrillation.
Does consumption of caffeinated coffee have a beneficial, detrimental, or neutral effect on the risk of recurrent atrial fibrillation (AF) episodes?
You might also wanna read
Personalized Vitamin D Supplementation Reduces Heart Attack Risk by 52% in Clinical Trial
A new randomized controlled trial called TARGET-D presented at the American Heart Association Scientific Sessions found that personalized vi
empirical.health·4mo ago
Study Links Long-Term Melatonin Use to Increased Heart Failure and Mortality Risks
A preliminary study presented at the American Heart Association's Scientific Sessions 2025 found that long-term melatonin use (one year or l
Study Reveals Myocardial Infarction May Be Caused by Bacterial Infections
A groundbreaking study by Finnish and UK researchers reveals that myocardial infarction (heart attack) may be an infectious disease, challen
tuni.fi·8mo ago
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
newscientist.com·21m ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·33m agoExperimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·33m ago